Chengyu Chu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
Papers in
-
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
- RNA modifications and cancer 2
- Ubiquitin and proteasome pathways 2
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Yiting Jin (11 shared papers)Qiang Zou (7 shared papers)Xiuping Liu (6 shared papers)Yun Cao (5 shared papers)Xiaoyan Li (5 shared papers)Jing He (4 shared papers)Hongying Wang (4 shared papers)Juan Yu (2 shared papers)
- Journals
- Oncogene (2 papers)Analytica Chimica Acta (1 paper)Bioorganic Chemistry (1 paper)International Journal of Oncology (1 paper)Annals of Translational Medicine (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Chengyu Chu
16 papers receiving 307 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 96
- Molecular Biology 224
- Biochemistry 21
- Aging 3
- Spectroscopy 28
Countries citing papers authored by Chengyu Chu
This map shows the geographic impact of Chengyu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyu Chu more than expected).
Fields of papers citing papers by Chengyu Chu
This network shows the impact of papers produced by Chengyu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyu Chu. The network helps show where Chengyu Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengyu Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 46 | |
| 2 | 2014 | 39 | |
| 3 | 2020 | 38 | |
| 4 | 2015 | 34 | |
| 5 | UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer. | 2015 | 33 |
| 6 | 2017 | 31 | |
| 7 | 2018 | 29 | |
| 8 | 2021 | 18 | |
| 9 | 2019 | 11 | |
| 10 | Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients. | 2019 | 9 |
| 11 | 2000 | 9 | |
| 12 | 2021 | 3 | |
| 13 | 1991 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2022 | 2 | |
| 16 | 國小教師資訊科技融入教學現況之研究 The Current State of Elementary School Teachers’ Information Technology Integration into Instruction | 2007 | 1 |
| 17 | 2024 | 0 | |
| 18 | 2017 | 0 |
About Chengyu Chu
Chengyu Chu is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 309 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Epigenetics and DNA Methylation (2 papers), Ferroptosis and cancer prognosis (2 papers), RNA Research and Splicing (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (96 citations), Molecular Biology (224 citations), Biochemistry (21 citations), Aging (3 citations) and Spectroscopy (28 citations). Chengyu Chu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Yiting Jin, Qiang Zou, Xiuping Liu, Yun Cao, Xiaoyan Li, Jing He, Hongying Wang, Juan Yu, Fei Gu and Mingxia Zhou. Their work appears in journals such as Oncogene, Analytica Chimica Acta, Bioorganic Chemistry, International Journal of Oncology and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.